This study investigates the use of carbon ion radiotherapy for patients with pancreatic cancer. The purpose of this study is to explore this treatment in individuals who are considered frail and cannot undergo surgery or chemotherapy.
The study focuses on assessing the safety and effectiveness of carbon ion radiotherapy. It evaluates how well this treatment works and its impact on patients' quality of life.
- Who can participate: Adults aged 19 and older with pancreatic cancer that has not spread can participate if they are ineligible for surgery or chemotherapy due to frailty or other medical conditions.
- Study details: Participants will receive carbon ion radiotherapy. The study will monitor their health and quality of life during and after treatment. A placebo is not used in this study.
- Study timelines: The study will last up to 2 years.
How understandable was the trial content above?
Hard to understand
Easy to understand